A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS).

[1]  F. H. van der Westhuizen,et al.  Metabolomics of mitochondrial disease. , 2017, Mitochondrion.

[2]  A. Paetau,et al.  Mitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism. , 2016, Cell metabolism.

[3]  W. Bockelmann,et al.  Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions , 2016, Front. Microbiol..

[4]  A. Regev,et al.  Mitochondrial dysfunction remodels one-carbon metabolism in human cells , 2015, eLife.

[5]  Robert W. Taylor,et al.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.

[6]  Robert W. Taylor,et al.  The urinary proteome and metabonome differ from normal in adults with mitochondrial disease. , 2015, Kidney international.

[7]  R. Naviaux.  Metabolic features of the cell danger response. , 2014, Mitochondrion.

[8]  J. Auwerx,et al.  Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 , 2014, EMBO molecular medicine.

[9]  L. T. Angenent,et al.  Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa , 2014, The ISME Journal.

[10]  M. Tomita,et al.  Metabolomic profiling rationalized pyruvate efficacy in cybrid cells harboring MELAS mitochondrial DNA mutations. , 2012, Mitochondrion.

[11]  R. Rodenburg,et al.  Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation , 2012, Journal of Inherited Metabolic Disease.

[12]  F. H. van der Westhuizen,et al.  Metabolomics of urinary organic acids in respiratory chain deficiencies in children , 2011, Metabolomics.

[13]  Robert W. Taylor,et al.  Prevalence of mitochondrial DNA disease in adults , 2008, Annals of neurology.

[14]  Nigel W. Hardy,et al.  The metabolomics standards initiative (MSI) , 2007, Metabolomics.

[15]  Nigel W. Hardy,et al.  The Metabolomics Standards Initiative , 2007, Nature Biotechnology.

[16]  P. Mitchell,et al.  Population prevalence of the MELAS A3243G mutation. , 2007, Mitochondrion.

[17]  Pierre Baldi,et al.  An enhanced MITOMAP with a global mtDNA mutational phylogeny , 2006, Nucleic Acids Res..

[18]  F. Scaglia,et al.  The Mitochondrial Myopathy Encephalopathy, Lactic Acidosis with Stroke-Like Episodes (MELAS) Syndrome , 2006, CNS drugs.

[19]  Massimo Zeviani,et al.  Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. , 2006, Cell metabolism.

[20]  A. Munnich,et al.  Clinical presentations and laboratory investigations in respiratory chain deficiency , 1996, European Journal of Pediatrics.

[21]  P. Bénit,et al.  Respiratory chain defects: what do we know for sure about their consequences in vivo? , 2004, Biochimica et biophysica acta.

[22]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[23]  S. Dimauro,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome , 1984, Annals of neurology.